Athanor Capital, LP Xoma Corp Transaction History

Athanor Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$29.0 - $40.64 $312,272 - $437,611	-10,768 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$33.21 - $43.99 $216,130 - $286,286	-6,508 Reduced 37.67%	10,768 $439,000
Q4 2020 Feb 16, 2021	BUY	$19.26 - $45.61 $113,306 - $268,323	5,883 Added 51.64%	17,276 $762,000
Q2 2020 Aug 13, 2020	BUY	$18.45 - $25.51 $210,200 - $290,635	11,393 New	11,393 $225,000
Q4 2019 Feb 14, 2020	SELL	$17.5 - $28.66 $444,500 - $727,964	-25,400 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.02 - $21.51 $231,308 - $331,254	15,400 Added 154.0%	25,400 $496,000
Q2 2019 Aug 13, 2019	BUY	$11.83 - $18.98 $118,300 - $189,800	10,000 New	10,000 $149,000

6.5M

100

1.6K

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $346M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.